sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> seasonal affective disorder market

report

Seasonal Affective Disorder Market, by Type (Fall and Winter SAD, Spring and Summer SAD, Others), Diagnosis (Physical Exam, Lab Tests, Psychological Evaluation, Others), Treatment (Light Therapy (Phototherapy), Medications, Psychotherapy, Counselling, Others), End-use (Hospital and Clinics, Academic Institutes, Medical Research Centers, Others) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC386 September 2017 100+ FREE 10% CUSTOMIZATION

A type of depression occurring over a certain period is known referred as Seasonal Affective Disorder.  This kind of disorder occurs mainly with the changing seasons, most of the time occurs in the winter season, but in few cases, people may have this the season of summers as well. It is most common in women, people in between the age group of 15 to 55, and those who are living far from the equator. Some key symptoms of this kind of disorder are the increased appetite, loss of the ability to concentrate, hopelessness, weight gain, social withdrawal, etc. There are certain risk factors related to such kind of disorder like Bipolar I disorder, major depressive disorder, Bipolar II disorder, and others.

The report on the global seasonal affective disorder market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Private companies and the government is investing heavily in the industry of healthcare for diagnosing, preventing, and treating infectious diseases. Growing investments in the drug development for the treatment of infectious diseases and increasing awareness associated with such kind of conditions are estimated to boost the growth of the seasonal affective disorder globally in the years to come.
  • Also, increasing no. of the expired patent as well as generic drugs entry in the global market for seasonal affective disorder is anticipated to boost the market demand for infectious disease therapeutics owing to low prices. Also, accessibility of diagnosis & treatment reimbursement of such infections is anticipated to boost the market growth of seasonal affective disorder.
  • However, lower penetration rate and large no. of available counterfeit drugs are anticipated to hamper the market growth of seasonal affective disorder over the forecast period.

Regionally, the global seasonal affective disorder market segmented into Europe, North America, Asia-Pacific, and the Rest of the World. Among these, North America region is the market leader in the global market for a seasonal affective disorder with maximum no. of shares in the past few years. Availability of huge no. of manufacturers, the positive scenario of reimbursement and increasing healthcare expenditure are major factors for largest maximum market share for this particular region. However, Asia Pacific region is more likely to grow with a maximum market share in the years to come.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s seasonal affective disorder market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the seasonal affective disorder market by the following segments:

  • Seasonal Affective Disorder Market, by Type
    • Fall and Winter SAD
    • Spring and Summer SAD
    • Others
  • Seasonal Affective Disorder Market, by Diagnosis
    • Physical Exam 
    • Lab Tests
    • Psychological Evaluation
    • Others
  • Seasonal Affective Disorder Market, by Treatment
    • Light Therapy (Phototherapy)
    • Medications
    • Psychotherapy
    • Counselling
    • Others
  • Seasonal Affective Disorder Market, by End-user
    • Hospital and Clinics
    • Academic Institutes
    • Medical Research Centers
    • Others

KEY MARKET PLAYERS

Key players in the seasonal affective disorder market include:

  • AbbVie Inc.
  • Allergan
  • Bayer AG
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Henry Schein, Inc.
  • Pfizer Inc.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Self-Care Medical Devices Market, by Product Types (Blood Glucose Monitors, Temperature Monitors, Blood Pressure Monitors, Holter Monitors, Sleep Apnea Monitors, Fertility Test Kits, Male External Catheter, Pedometers, Nebulizers, Insulin Devices and Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
  5. SEASONAL AFFECTIVE DISORDER MARKET, BY TYPE
    1. Segment Share
    2. By Type
      1. Fall and Winter SAD
      2. Spring and Summer SAD
      3. Others
  6. SEASONAL AFFECTIVE DISORDER MARKET, BY DIAGNOSIS
    1. Segment Share
    2. By Diagnosis
      1. Physical Exam 
      2. Lab Tests
      3. Psychological Evaluation
      4. Others
  7. SEASONAL AFFECTIVE DISORDER MARKET, BY TREATMENT
    1. Segment Share
    2. By Treatment
      1. Light Therapy (Phototherapy)
      2. Medications
      3. Psychotherapy
      4. Counselling
      5. Others
  8. SEASONAL AFFECTIVE DISORDER MARKET, BY END-USER
    1. Segment Share
    2. By End-user
      1. Hospital and Clinics
      2. Academic Institutes
      3. Medical Research Centers
      4. Others
  9. SEASONAL AFFECTIVE DISORDER MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Type
      3. By Diagnosis
      4. By Treatment
      5. By End-user
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Type
      3. By Diagnosis
      4. By Treatment
      5. By End-user
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Type
      3. By Diagnosis
      4. By Treatment
      5. By End-user
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Type
      3. By Diagnosis
      4. By Treatment
      5. By End-user
  10. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  11. KEY MARKET PLAYERS
    1. AbbVie Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Allergan
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Bayer AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Bristol-Myers Squibb Company
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. F. Hoffmann-La Roche Ltd.
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Henry Schein, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Pfizer Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
  12. SCALAR 360 DEGREE MARKET PERSPECTIVE
  13. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us